skip to main content

"Nur zu bestimmten Zeiten essen: Was bringt's?"

Deutschlandfunk Nova in an interview with CMFI Principal Investigator Prof. Dr. Mathias Heikenwälder on intermittent fasting

18.02.2026 In the Media

In an interview with Deutschlandfunk Nova, molecular biologist and CMFI Principal Investigator Prof. Dr. Mathias Heikenwälder provides insights into the current state of research on intermittent fasting. He confirms that it works, though not necessarily better than other fasting methods, and explains which method studies have shown to be the most effective: the 5:2 fast, in which you consume a normal amount of calories for five days and then only 300-400 calories for two days, provides the best chance of long-term success.

 

Go to interview (available only in German)

Scientific Contact

Prof. Dr. Mathias Heikenwälder

University Hospital of Tübingen
Scientific Director M3 Research Center

E-Mail: mathias.heikenwaelder@med.uni-tuebingen.de

Website

Press Contact

Leon Kokkoliadis
Public Relations Management

Tel: +49 7071 29-74707 / +49 152 346 79 269
E-Mail: leon.kokkoliadis@uni-tuebingen.de

Related News

Gut microbes help set the body’s response to vaccination
08.10.2026 Gut microbes help set the body’s response to vaccination Press Release
Dietary fiber does not act alone in the microbiome
06.10.2026 Dietary fiber does not act alone in the microbiome Press Release
"Blaualgen werden missverstanden: Warum Cyanobakterien auch Lebensretter sind" (German only)
03.09.2026 "Blaualgen werden missverstanden: Warum Cyanobakterien auch Lebensretter sind" (German only) In the Media

Frankfurter Allgemeine Zeitung

Even ancient bacteria possessed intercellular communication structures like humans today
31.08.2026 Even ancient bacteria possessed intercellular communication structures like humans today Press Release
Lars Angenent Part of the Funding Program "99 Projects"
24.08.2026 Lars Angenent Part of the Funding Program "99 Projects" CMFI News
€1.8 million for new approaches to tackling antibiotic-resistant bacteria
20.08.2026 €1.8 million for new approaches to tackling antibiotic-resistant bacteria CMFI News